BiotechTube

Nicotine

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Tobacco Dependence

Conditions

Tobacco Dependence

Trial Timeline

Nov 1, 2008 → Jan 1, 2009

NCT ID
NCT01152736

About Nicotine

Nicotine is a pre-clinical stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01152736. Target conditions include Tobacco Dependence.

What happened to similar drugs?

7 of 10 similar drugs in Tobacco Dependence were approved

Approved (7) Terminated (3) Active (2)
✅Nicotine Gum + Nicotine PatchJohnson & JohnsonApproved
🔄Nicotine Spray + PlaceboJohnson & JohnsonPhase 3
❌Placebo + NicotineJohnson & JohnsonPhase 3
✅Bupropion SRJohnson & JohnsonApproved
✅Varenicline + Nicotine Patch + Placebo Patch + Placebo TabletPfizerApproved
✅1.0mg Varenicline b.i.d. + 0.5mg Varenicline b.i.d. + 0.0mg placebo Varenicline b.i.d.PfizerApproved
✅Varenicline Tartrate + PlaceboPfizerApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01152736Pre-clinicalCompleted
NCT01152723Pre-clinicalCompleted

Competing Products

20 competing products in Tobacco Dependence

See all competitors
ProductCompanyStageHype Score
Nicotine + Nicotine + NicotineJohnson & JohnsonPre-clinical
26
Nicotine Gum + Nicotine PatchJohnson & JohnsonApproved
43
Nicotine Medicated Gum + 4 mg Nicotine Gum + 2 mg Nicotine Gum + 4 mg Nicotine LozengeJohnson & JohnsonPre-clinical
26
Nicotine + NicotineJohnson & JohnsonPre-clinical
26
Nicotine + NicotineJohnson & JohnsonPhase 1
29
Nicotine + Nicotine + NicotineJohnson & JohnsonPhase 1
29
NicotineJohnson & JohnsonPre-clinical
26
6 mg Experimental nicotine gum + 4 mg Nicotine Gum/ + 2 mg Nicotine GumJohnson & JohnsonPre-clinical
26
Nicorette Strongmint lozenge 4 mg + Niquitin MiniMint lozenge 4 mgJohnson & JohnsonPhase 1
29
Oral Nicotine + Nicotine Lozenge + Nicotine gumJohnson & JohnsonPre-clinical
26
Nicotine + Nicotine GumJohnson & JohnsonPre-clinical
26
Code STD + Code STE + Nicorette MicrotabJohnson & JohnsonPre-clinical
26
Experimental Nicotine Replacement Therapy (NRT) 2 mg + Experimental Nicotine Replacement Therapy (NRT) + Marketed Nicotine Lozenge + Marketed Nicotine LozengeJohnson & JohnsonPre-clinical
26
Nicotine + Nicorette® (Nicotine Gum)Johnson & JohnsonPre-clinical
26
Nicotine + Nicotine GumJohnson & JohnsonPre-clinical
26
Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine TabletJohnson & JohnsonPre-clinical
26
Nicotine Spray + PlaceboJohnson & JohnsonPhase 3
40
Placebo + NicotineJohnson & JohnsonPhase 3
32
Bupropion SRJohnson & JohnsonApproved
35
Nicorette Extra Mint 2 mg Gum + Nicorette Mint 2 mg Gum + Nicorette Extra Mint 4mg Gum + Nicorette Mint 4 mg GumJohnson & JohnsonPhase 1
29